🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Tomorrow is the EU open day! Anne May and Anouk Hiensch will represent the PREFERABLE II Consortium. We are looking forward to meeting you at the Green Village! #HorizonEurope #MissionCancer #CancerResearch

#EUOpenDay is in full swing! 💃 Happy to see so many visitors interested in our #EUMissions and especially #MissionCancer 💜

The PREFERABLE II project was showcased during the #EUOpenDay! We informed many visitors about the project and measured their handgrip strength, which we often do with pts in our exercise-oncology trials to evaluate exercise effects. #EUCancerMission #EUHealthResearch HaDEA

Congratulations to the PREFERABLE_II team for the great work recognised at the #EUOpenDay! The importance of #physicalactivity for #cancerpatients and #survivors was highlighted this week at the Annual Congress of FAVO F.A.V.O. an ECPC @cancereu member #EUHealthResearch #HADEA

Did you visit #MissionCancer and projects ULTRAPLACAD & PREFERABLE_II at the #EUOpenDay? #EUfunded R&I is the Mission’s ally in reaching its objectives: 🎯Improve understanding 🎯Prevention 🎯Cure 🎯QoL On day 3 of #EWAC2023 discover this #EUMission 👇 europa.eu/!krPMGF

Wir bieten DKFZ: Promotionsstelle im Bereich Bewegung während/nach einer Krebserkrankung für unser EU-Projekt PREFERABLE_II. Nähere Infos unter: jobs.dkfz.de/de/jobs/155668…

Just published by our team at Exercise Medicine Research Institute led by Brendan Crosby co-authored with Pedro Lopez Tarek Meniawy Wei-Sen Lam ElinGrayPhD Favil Singh An 8-week telehealth exercise intervention is feasible and safe for patients with advanced melanoma and appears to improve

The PREFERABLE-II consortium met in Hannover 7-8 Sept. We are now finalizing the protocol for the clinical trial (LION-RCT), survey and focus groups (LION-COM and ELSI). Also legal and ethical aspects of live-remote training were discussed. #HorizonEU

Great to discuss the PREFERABLE II live-remote exercise program with our advisor Kerri Winters-Stone today. Thank you! The program will be evaluated in the LION RCT starting Q1 2024. #HorizonEU HaDEA #ExerciseOncology

Nice to meet the MyPath colleagues in Edinburgh and discuss their project. MyPath is led by stein Kaasa and Marie Fallon👇. MyPath aims to implement patient-centred care pathways in a digital solution for patients with cancer. Working together in the #QoL_Cluster HaDEA

I couldn't do this w/o the fantastic PREF-II women Professor Anna Campbell MBE Anna Lyubenova Eva Zopf @JanaMueller11er Karen Steindorf @Mireia_Paleaz Anouk Hiensch @ElskenvdWall Dorothea Clauss Helene Rundqvist @depenbusch_j Kathi Apostolidis Lonneke van de Poll Renske K-A Poorna Anand Yvonne Wengström Andreia Capela

Congrats to our PREFERABLE_II colleagues for these promising findings! Alberto C Alves Andreia Capela Cardio-Oncology Rehabilitation for Cancer Survivors With High Cardiovascular Risk jamanetwork.com/journals/jamac…

🗣️Ben jij afgelopen jaar behandeld voor kanker en heb je interesse in deelname aan een focusgroep? Ga in gesprek over online beweegprogramma’s na de behandeling van kanker. Interesse? Meer informatie en aanmelden kan hier: lnkd.in/ez-jXk3G NFK Erfelijke borstkanker Antoni van Leeuwenhoek

Informing all Dutch oncologists about the positive effects of exercise as strategy to prevent cancer, improve prognosis & reduce side effects during and after treatment & the LION study, which is about to start recruitment. Anne May Anouk Hiensch Horizon Europe 🇪🇺 #oncologiedagen

Testing the base module of the LION exercise program with the PREFERABLE II team. We are almost ready to start recruitment! Horizon Europe 🇪🇺 EU Science & Innovation 🇪🇺 Professor Anna Campbell MBE Evelyn Monninkhof Jana Müller

During our 4th consortium meeting in Stockholm, we discussed the progression of our clinical trial (LION-RCT), survey and focus groups (LION-COM and ELSI) at each site. We are happy to announce that the first center (UMCU) has started inclusions for the clinical trial! #HorizonEU

The PREFERABLE_II LION RCT has started! The 1st participants UMC Utrecht & The Netherlands Cancer Institute have signed consent. Thanks Lifemaxx for sending & sponsoring training materials! LION investigates effects of life remote exercise for patients after cancer treatment preferable2.eu

A great morning in Boston at the planning meeting of the International Society of Exercise Oncology #ISEO. Also great to see Anne May presenting the preferable consortium as an excellent example for multi center international trials. PREFERABLE PREFERABLE_II

The PREFERABLE II Consortium was well represented during the #ISEO pre-conference at #ACSM24. Anne May presented the PREFERABLE studies as example of successful multinational exercise oncology RCTs, showing that teamwork makes the dream work.

🙏 to @Europadonna for participating in @preferable_mbc & representing the patients' perspective. It was a pleasure working and continue working with you. I also thank the European Commissioner Stella Kyriakides for her video message on PREFERABLE's results: vimeo.com/980735575